CLOs on the Move


 
Eledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular transplantation, and for people with autoimmune and neurodegenerative disease. Our lead program, AT-1501, is a potential best-in-class humanized IgG1 anti-CD40L antibody with high affinity for CD40L, a well-validated biological target with broad therapeutic potential. The CD40/CD40L pathway plays a central role in generating pro-inflammatory responses in autoimmune disease, allograft transplant rejection, and neuroinflammation.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.eledon.com
  • 19900 MacArthur Boulevard Suite 550
    Irvine, CA USA 92612
  • Phone: 949.238.8090

Executives

Name Title Contact Details
David Hovland
Chief Regulatory Officer Profile
Bryan Smith
General Counsel, Corporate Secretary, and Chief Compliance Officer Profile

Similar Companies

Sebia

Sebia is the world’s leading provider of clinical protein electrophoresis equipment and reagents for various diseases screening and monitoring.

Pharma Logistics

Pharma Logistics is a full service reverse distributor of overstock, expired and in-dated pharmaceutical products. We provide a complete returns solution, 24/7 access to our online client portal and industry leading reporting tools that can present better alternatives to existing purchasing decisions.

Pharmaprint Inc

Pharmaprint Inc is a Newport Beach, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.